Furthermore, recent investigations into pan-immune-inflammatory values and the albumin-to-globulin ratio in CRC highlight the superior prognostic power achieved by integrating tumor markers with immune-inflammatory indicators [34]. The gene discussed is ALB; the disease is colorectal carcinoma.